“QIAGEN” QuantiFERON-TB Gold Plus (QFT-Plus) - Taiwan Registration 0e40d853910a101ae5ff235d138ef60e
Access comprehensive regulatory information for “QIAGEN” QuantiFERON-TB Gold Plus (QFT-Plus) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 0e40d853910a101ae5ff235d138ef60e and manufactured by QIAGEN. The authorized representative in Taiwan is QIAGEN TAIWAN COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
0e40d853910a101ae5ff235d138ef60e
Ministry of Health Medical Device Import No. 032488
DHA05603248801
Product Details
This product is an in vitro diagnostic detection reagent, using ESAT-6 and CFP-10 peptide antigen to stimulate cells in heparinized whole blood, and using enzyme immunoassay (ELISA) to detect interferon (IFN-γ) produced by the in vitro reaction of peptide antigen to determine whether it is infected by tuberculosis. This product is a test for indirect detection of tuberculosis infection, including morbidity, and is evaluated in conjunction with risk assessment, radiography, and other medical and diagnostic results.
B Hematology and pathology devices
B4020 Analyze specific reagents
Imported from abroad
Dates and Status
Aug 29, 2019
Aug 29, 2024

